MediClin AG (XTER:MED) Change In Receivables : €0.0 Mil (TTM As of Dec. 2023)

View and export this data going back to 2000. Start your Free Trial

What is MediClin AG Change In Receivables?

MediClin AG's change in receivables for the quarter that ended in Dec. 2023 was €0.0 Mil. It means MediClin AG's Accounts Receivable stayed the same from Sep. 2023 to Dec. 2023 .

MediClin AG's change in receivables for the fiscal year that ended in Dec. 2023 was €0.0 Mil. It means MediClin AG's Accounts Receivable stayed the same from Dec. 2022 to Dec. 2023 .

MediClin AG's Accounts Receivable for the quarter that ended in Dec. 2023 was €81.6 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. MediClin AG's Days Sales Outstanding for the three months ended in Dec. 2023 was 40.69.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. MediClin AG's liquidation value for the three months ended in Dec. 2023 was €-504.4 Mil.

MediClin AG Change In Receivables Historical Data

The historical data trend for MediClin AG's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MediClin AG Change In Receivables Chart

MediClin AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

Get a 7-Day Free Trial

MediClin AG Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Change In Receivables	Get a 7-Day Free Trial															-	-	-	-	-

MediClin AG Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.0 Mil.

MediClin AG (XTER:MED) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

MediClin AG's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	81.581	/	182.964	*	91
=	40.69

2. In Ben Graham's calculation of liquidation value, MediClin AG's accounts receivable are only considered to be worth 75% of book value:

MediClin AG's liquidation value for the quarter that ended in Dec. 2023 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	115.286	-	684.473	+	0.75 * 81.581	+	0.5 * 7.296
=	-504.4

MediClin AG Change In Receivables Related Terms

Thank you for viewing the detailed overview of MediClin AG's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

MediClin AG (XTER:MED) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » MediClin AG (XTER:MED) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

MED:Germany MED:Germany

Address

Okenstrasse 27, Offenburg, DEU, 77652

Website

https://www.mediclin.de

MediClin AG is a company engaged in operating hospitals. It is focused on providing services in the areas of neurosciences and psychological sciences as well as orthopedics in Germany. The hospitals are acute-care hospitals providing basic, standard, and specialized care, as well as specialist clinics for medical rehabilitation. The operating segments of the group are Post-acute, Acute and Other activities. It generates majority of the revenue from the Post-acute segment in which the firm offers services in the fields of subsequent nursing treatment and curative treatment. Subsequent nursing treatment starts after acute care treatment and includes all medical measures required to facilitate the healing process and return the patient to a functioning state.